_id

69171f763c536f8df231680a

Ticker

TLX

Name

Telix Pharmaceuticals Limited

Exchange

NASDAQ

Address

55 Flemington Road, North Melbourne, VIC, Australia, 3051

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://telixpharma.com

Description

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250, an rADC for treating advanced metastatic kidney cancer; TLX101, a systemic therapy for the treatment of glioblastoma; TLX66, a product candidate for bone marrow conditioning for hematopoietic stem cell transplant conditioning; and Illuccix and Gozellix for the treatment of prostate cancer. The company is also developing TLX592, a prostate cancer therapy candidate for targeted alpha therapy based on its proprietary RADmAb-engineered antibody technology; TLX252 for the treatment of patients with advanced metastatic kidney cancer; TLX400, a bladder fibroblast activation protein for treating various tumors; TLX102, a large amino acid transporter-targeting small molecule-based alpha therapy candidate for the treatment of glioblastoma and multiple myeloma; TLX300 for treating soft tissue sarcoma; and TLX090, a bone-seeking agent for bone metastases and pain palliation. In addition, it is developing TLX250-CDx, a positron emission tomography (PET) diagnostic imaging agent for the characterization of renal masses as clear cell renal cell carcinoma; TLX101-CDx, a PET diagnostic agent to image cancerous lesions in the brain; and TLX66-CDx, a cluster of differentiation 66 imaging agent for osteomyelitis (bone infection). It operates in Australia, Belgium, Canada, the United Kingdom, the United States, and internationally. The company was founded in 2015 and is headquartered in North Melbourne, Australia.

Last Close

7.5

Volume

173475

Current Price

7.76

Change

-0.12

Last Updated

2026-01-07T13:13:45.984Z

Image

https://logo.clearbit.com/telixpharma.com

Ipo Date

2024-11-14T00:00:00.000Z

Market Cap

3277215744

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-0.06245932203389834

Sentiment Sources

59

Rating

5

Target Price

20.895

Strong Buy

2

Buy

0

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-06-30

Revenue

593111464

Cost Of Revenue

304768849

Gross Profit

288342615

Operating Expenses

272556049

Operating Income

15786566

Interest Expense

3920052

Pretax Income

-7347818

Net Income

-3482464

Eps

-0.010327505227854982

Dividends Per Share

-

Shares Outstanding

334724485

Income Tax Expense

3865353

EBITDA

8905203

Operating Margin

2.661652481564578

Total Other Income Expense Net

-23134384

Cash

207156000

Short Term Investments

-

Receivables

129523000

Inventories

35230000

Total Current Assets

398013000

Property Plant Equipment

74177000

Total Assets

1189952000

Payables

51685000

Short Term Debt

21064000

Long Term Debt

371478000

Total Liabilities

768011000

Equity

421941000

Bs_currency_symbol

USD

Depreciation

14563449

Change In Working Capital

-

Cash From Operations

26967830

Capital Expenditures

10131359

Cash From Investing

-393302767

Cash From Financing

-4441206

Net Change In Cash

314752826

Cf_currency_symbol

-

PE

475.5

PB

6.201563651221379

ROE

-0.8253438276915492

ROA

-0.29265583821868446

FCF

16836471

Fcf Percent

0.02838668955486586

Piotroski FScore

2

Health Score

19

Deep Value Investing Score

4

Defensive Investing Score

5.5

Dividend Investing Score

3

Economic Moat Investing Score

5.8

Garp Investing Score

3

Growth Investing Score

3

Momentum Investing Score

6

Net Net Investing Score

2.5

Quality Investing Score

4.5

Value Investing Score

3

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

593111464

Quarters > 0 > income Statement > cost Of Revenue

304768849

Quarters > 0 > income Statement > gross Profit

288342615

Quarters > 0 > income Statement > operating Expenses

272556049

Quarters > 0 > income Statement > operating Income

15786566

Quarters > 0 > income Statement > interest Expense

3920052

Quarters > 0 > income Statement > pretax Income

-7347818

Quarters > 0 > income Statement > net Income

-3482464

Quarters > 0 > income Statement > eps

-0.010327505227854982

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

337202831

Quarters > 0 > income Statement > income Tax Expense

3865353

Quarters > 0 > income Statement > EBITDA

8905203

Quarters > 0 > income Statement > operating Margin

2.661652481564578

Quarters > 0 > income Statement > total Other Income Expense Net

-23134384

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

207156000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

129523000

Quarters > 0 > balance Sheet > inventories

35230000

Quarters > 0 > balance Sheet > total Current Assets

398013000

Quarters > 0 > balance Sheet > property Plant Equipment

74177000

Quarters > 0 > balance Sheet > total Assets

1189952000

Quarters > 0 > balance Sheet > payables

51685000

Quarters > 0 > balance Sheet > short Term Debt

21064000

Quarters > 0 > balance Sheet > long Term Debt

371478000

Quarters > 0 > balance Sheet > total Liabilities

768011000

Quarters > 0 > balance Sheet > equity

421941000

Quarters > 0 > balance Sheet > currency_symbol

USD

Quarters > 0 > cash Flow > net Income

-3482464

Quarters > 0 > cash Flow > depreciation

14563449

Quarters > 0 > cash Flow > change In Working Capital

-

Quarters > 0 > cash Flow > cash From Operations

26967830

Quarters > 0 > cash Flow > capital Expenditures

10131359

Quarters > 0 > cash Flow > cash From Investing

-393302767

Quarters > 0 > cash Flow > cash From Financing

-4441206

Quarters > 0 > cash Flow > net Change In Cash

314752826

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

-0.010327505227854982

Quarters > 0 > ratios > PB

6.201563651221379

Quarters > 0 > ratios > ROE

-0.8253438276915492

Quarters > 0 > ratios > ROA

-0.29265583821868446

Quarters > 0 > ratios > FCF

16836471

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

0.02838668955486586

Quarters > 0 > health Score

19

Quarters > 1 > quarter

2024-12-31

Quarters > 1 > income Statement > revenue

594244000

Quarters > 1 > income Statement > cost Of Revenue

208447000

Quarters > 1 > income Statement > gross Profit

385797000

Quarters > 1 > income Statement > operating Expenses

317419000

Quarters > 1 > income Statement > operating Income

68378000

Quarters > 1 > income Statement > interest Expense

16521000

Quarters > 1 > income Statement > pretax Income

46913000

Quarters > 1 > income Statement > net Income

38239000

Quarters > 1 > income Statement > eps

0.11077731554978736

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

345188000

Quarters > 1 > income Statement > income Tax Expense

8674000

Quarters > 1 > income Statement > EBITDA

76800000

Quarters > 1 > income Statement > operating Margin

11.50672114484959

Quarters > 1 > income Statement > total Other Income Expense Net

-21465000

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

710346000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

158994000

Quarters > 1 > balance Sheet > inventories

38144000

Quarters > 1 > balance Sheet > total Current Assets

918564000

Quarters > 1 > balance Sheet > property Plant Equipment

54321000

Quarters > 1 > balance Sheet > total Assets

1516431000

Quarters > 1 > balance Sheet > payables

68698000

Quarters > 1 > balance Sheet > short Term Debt

21486000

Quarters > 1 > balance Sheet > long Term Debt

551821000

Quarters > 1 > balance Sheet > total Liabilities

948218000

Quarters > 1 > balance Sheet > equity

568213000

Quarters > 1 > balance Sheet > currency_symbol

AUD

Quarters > 1 > cash Flow > net Income

-11680000

Quarters > 1 > cash Flow > depreciation

-1995000

Quarters > 1 > cash Flow > change In Working Capital

-64271000

Quarters > 1 > cash Flow > cash From Operations

3948000

Quarters > 1 > cash Flow > capital Expenditures

20336000

Quarters > 1 > cash Flow > cash From Investing

-89332000

Quarters > 1 > cash Flow > cash From Financing

635305000

Quarters > 1 > cash Flow > net Change In Cash

591509000

Quarters > 1 > cash Flow > currency_symbol

-

Quarters > 1 > ratios > PE

0.11077731554978736

Quarters > 1 > ratios > PB

4.7141809145514095

Quarters > 1 > ratios > ROE

6.729694674356271

Quarters > 1 > ratios > ROA

2.5216445720247083

Quarters > 1 > ratios > FCF

-16388000

Quarters > 1 > ratios > Piotroski FScore

3

Quarters > 1 > ratios > fcf Percent

-0.027577897294713955

Quarters > 1 > health Score

43

Quarters > 2 > quarter

2024-06-30

Quarters > 2 > income Statement > revenue

188963000

Quarters > 2 > income Statement > cost Of Revenue

65082000

Quarters > 2 > income Statement > gross Profit

123881000

Quarters > 2 > income Statement > operating Expenses

110129000

Quarters > 2 > income Statement > operating Income

13752000

Quarters > 2 > income Statement > interest Expense

4943000

Quarters > 2 > income Statement > pretax Income

9143000

Quarters > 2 > income Statement > net Income

11680000

Quarters > 2 > income Statement > eps

0.03330000007127568

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

350750750

Quarters > 2 > income Statement > income Tax Expense

-2537000

Quarters > 2 > income Statement > EBITDA

40291000

Quarters > 2 > income Statement > operating Margin

7.277615194508978

Quarters > 2 > income Statement > total Other Income Expense Net

-4609000

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

118837000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

97273000

Quarters > 2 > balance Sheet > inventories

30803000

Quarters > 2 > balance Sheet > total Current Assets

255261000

Quarters > 2 > balance Sheet > property Plant Equipment

38255000

Quarters > 2 > balance Sheet > total Assets

745958000

Quarters > 2 > balance Sheet > payables

22307952

Quarters > 2 > balance Sheet > short Term Debt

3781009

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

341984000

Quarters > 2 > balance Sheet > equity

403974000

Quarters > 2 > balance Sheet > currency_symbol

-

Quarters > 2 > cash Flow > net Income

11680000

Quarters > 2 > cash Flow > depreciation

1995000

Quarters > 2 > cash Flow > change In Working Capital

-

Quarters > 2 > cash Flow > cash From Operations

34979334

Quarters > 2 > cash Flow > capital Expenditures

13696000

Quarters > 2 > cash Flow > cash From Investing

-45622155

Quarters > 2 > cash Flow > cash From Financing

3618000

Quarters > 2 > cash Flow > net Change In Cash

-3871000

Quarters > 2 > cash Flow > currency_symbol

-

Quarters > 2 > ratios > PE

0.03330000007127568

Quarters > 2 > ratios > PB

6.737626233371454

Quarters > 2 > ratios > ROE

2.89127518107601

Quarters > 2 > ratios > ROA

1.5657717994846894

Quarters > 2 > ratios > FCF

21283334

Quarters > 2 > ratios > Piotroski FScore

4

Quarters > 2 > ratios > fcf Percent

0.1126322825103327

Quarters > 2 > health Score

52

Quarters > 3 > quarter

2023-12-31

Quarters > 3 > income Statement > revenue

281713000

Quarters > 3 > income Statement > cost Of Revenue

57738000

Quarters > 3 > income Statement > gross Profit

223975000

Quarters > 3 > income Statement > operating Expenses

203900000

Quarters > 3 > income Statement > operating Income

20075000

Quarters > 3 > income Statement > interest Expense

548000

Quarters > 3 > income Statement > pretax Income

15387000

Quarters > 3 > income Statement > net Income

19531000

Quarters > 3 > income Statement > eps

0.060331699240409355

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

323727000

Quarters > 3 > income Statement > income Tax Expense

-4144000

Quarters > 3 > income Statement > EBITDA

22994000

Quarters > 3 > income Statement > operating Margin

7.126046721308565

Quarters > 3 > income Statement > total Other Income Expense Net

-4688000

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

123237000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

64777000

Quarters > 3 > balance Sheet > inventories

17310000

Quarters > 3 > balance Sheet > total Current Assets

224848000

Quarters > 3 > balance Sheet > property Plant Equipment

30493000

Quarters > 3 > balance Sheet > total Assets

398302000

Quarters > 3 > balance Sheet > payables

32837000

Quarters > 3 > balance Sheet > short Term Debt

1559000

Quarters > 3 > balance Sheet > long Term Debt

8209000

Quarters > 3 > balance Sheet > total Liabilities

249391000

Quarters > 3 > balance Sheet > equity

148911000

Quarters > 3 > balance Sheet > currency_symbol

AUD

Quarters > 3 > cash Flow > net Income

19531000

Quarters > 3 > cash Flow > depreciation

3639000

Quarters > 3 > cash Flow > change In Working Capital

-57534000

Quarters > 3 > cash Flow > cash From Operations

10625000

Quarters > 3 > cash Flow > capital Expenditures

7785000

Quarters > 3 > cash Flow > cash From Investing

-22603000

Quarters > 3 > cash Flow > cash From Financing

5485000

Quarters > 3 > cash Flow > net Change In Cash

-8492000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

0.060331699240409355

Quarters > 3 > ratios > PB

16.869952656284624

Quarters > 3 > ratios > ROE

13.115888013645735

Quarters > 3 > ratios > ROA

4.903565636125353

Quarters > 3 > ratios > FCF

2840000

Quarters > 3 > ratios > Piotroski FScore

3

Quarters > 3 > ratios > fcf Percent

0.010081181912087834

Quarters > 3 > health Score

46

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

783207000

Annuals > 0 > income Statement > cost Of Revenue

273529000

Annuals > 0 > income Statement > gross Profit

509678000

Annuals > 0 > income Statement > operating Expenses

427548000

Annuals > 0 > income Statement > operating Income

82130000

Annuals > 0 > income Statement > interest Expense

21464000

Annuals > 0 > income Statement > pretax Income

56056000

Annuals > 0 > income Statement > net Income

49919000

Annuals > 0 > income Statement > eps

0.14461394949998263

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

345188000

Annuals > 0 > income Statement > income Tax Expense

6137000

Annuals > 0 > income Statement > EBITDA

98233000

Annuals > 0 > income Statement > operating Margin

10.486372057450968

Annuals > 0 > income Statement > total Other Income Expense Net

-26074000

Annuals > 0 > income Statement > currency_symbol

AUD

Annuals > 0 > balance Sheet > cash

710346000

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

158994000

Annuals > 0 > balance Sheet > inventories

38144000

Annuals > 0 > balance Sheet > total Current Assets

918564000

Annuals > 0 > balance Sheet > property Plant Equipment

54321000

Annuals > 0 > balance Sheet > total Assets

1516431000

Annuals > 0 > balance Sheet > payables

68698000

Annuals > 0 > balance Sheet > short Term Debt

21486000

Annuals > 0 > balance Sheet > long Term Debt

551821000

Annuals > 0 > balance Sheet > total Liabilities

948218000

Annuals > 0 > balance Sheet > equity

568213000

Annuals > 0 > balance Sheet > currency_symbol

AUD

Annuals > 0 > cash Flow > net Income

49919000

Annuals > 0 > cash Flow > depreciation

5686000

Annuals > 0 > cash Flow > change In Working Capital

-64271000

Annuals > 0 > cash Flow > cash From Operations

43029000

Annuals > 0 > cash Flow > capital Expenditures

34032000

Annuals > 0 > cash Flow > cash From Investing

-135173000

Annuals > 0 > cash Flow > cash From Financing

638923000

Annuals > 0 > cash Flow > net Change In Cash

587109000

Annuals > 0 > cash Flow > currency_symbol

AUD

Annuals > 0 > ratios > PE

0.14461394949998263

Annuals > 0 > ratios > PB

4.5319316523909166

Annuals > 0 > ratios > ROE

8.785261864828858

Annuals > 0 > ratios > ROA

3.291874143960391

Annuals > 0 > ratios > FCF

8997000

Annuals > 0 > ratios > Piotroski FScore

3

Annuals > 0 > ratios > fcf Percent

0.011487384561169652

Annuals > 0 > health Score

44

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

502547000

Annuals > 1 > income Statement > cost Of Revenue

188157000

Annuals > 1 > income Statement > gross Profit

314390000

Annuals > 1 > income Statement > operating Expenses

263273000

Annuals > 1 > income Statement > operating Income

51887000

Annuals > 1 > income Statement > interest Expense

13558000

Annuals > 1 > income Statement > pretax Income

3087000

Annuals > 1 > income Statement > net Income

5211000

Annuals > 1 > income Statement > eps

0.016097741805937413

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

323710000

Annuals > 1 > income Statement > income Tax Expense

-2124000

Annuals > 1 > income Statement > EBITDA

22966000

Annuals > 1 > income Statement > operating Margin

10.324805441083122

Annuals > 1 > income Statement > total Other Income Expense Net

-48800000

Annuals > 1 > income Statement > currency_symbol

AUD

Annuals > 1 > balance Sheet > cash

123237000

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

79535000

Annuals > 1 > balance Sheet > inventories

17310000

Annuals > 1 > balance Sheet > total Current Assets

224848000

Annuals > 1 > balance Sheet > property Plant Equipment

30493000

Annuals > 1 > balance Sheet > total Assets

398302000

Annuals > 1 > balance Sheet > payables

32837000

Annuals > 1 > balance Sheet > short Term Debt

1559000

Annuals > 1 > balance Sheet > long Term Debt

8209000

Annuals > 1 > balance Sheet > total Liabilities

249391000

Annuals > 1 > balance Sheet > equity

148911000

Annuals > 1 > balance Sheet > currency_symbol

AUD

Annuals > 1 > cash Flow > net Income

5211000

Annuals > 1 > cash Flow > depreciation

6924000

Annuals > 1 > cash Flow > change In Working Capital

-57534000

Annuals > 1 > cash Flow > cash From Operations

23884000

Annuals > 1 > cash Flow > capital Expenditures

10794000

Annuals > 1 > cash Flow > cash From Investing

-25489000

Annuals > 1 > cash Flow > cash From Financing

10186000

Annuals > 1 > cash Flow > net Change In Cash

6908000

Annuals > 1 > cash Flow > currency_symbol

AUD

Annuals > 1 > ratios > PE

0.016097741805937413

Annuals > 1 > ratios > PB

16.21691211529034

Annuals > 1 > ratios > ROE

3.499405685275097

Annuals > 1 > ratios > ROA

1.308303749416272

Annuals > 1 > ratios > FCF

13090000

Annuals > 1 > ratios > Piotroski FScore

3

Annuals > 1 > ratios > fcf Percent

0.026047314977504593

Annuals > 1 > health Score

37

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

160096000

Annuals > 2 > income Statement > cost Of Revenue

130759000

Annuals > 2 > income Statement > gross Profit

29337000

Annuals > 2 > income Statement > operating Expenses

102517000

Annuals > 2 > income Statement > operating Income

-91930000

Annuals > 2 > income Statement > interest Expense

406000

Annuals > 2 > income Statement > pretax Income

-98622000

Annuals > 2 > income Statement > net Income

-104079000

Annuals > 2 > income Statement > eps

-0.33504268551782745

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

310644000

Annuals > 2 > income Statement > income Tax Expense

5457000

Annuals > 2 > income Statement > EBITDA

-92837000

Annuals > 2 > income Statement > operating Margin

-57.42179692184689

Annuals > 2 > income Statement > total Other Income Expense Net

-6692000

Annuals > 2 > income Statement > currency_symbol

USD

Annuals > 2 > balance Sheet > cash

116329000

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

31139969

Annuals > 2 > balance Sheet > inventories

5766902

Annuals > 2 > balance Sheet > total Current Assets

173233000

Annuals > 2 > balance Sheet > property Plant Equipment

18838000

Annuals > 2 > balance Sheet > total Assets

260591000

Annuals > 2 > balance Sheet > payables

16806000

Annuals > 2 > balance Sheet > short Term Debt

641000

Annuals > 2 > balance Sheet > long Term Debt

3312000

Annuals > 2 > balance Sheet > total Liabilities

175346000

Annuals > 2 > balance Sheet > equity

80007000

Annuals > 2 > balance Sheet > currency_symbol

AUD

Annuals > 2 > cash Flow > net Income

-104079000

Annuals > 2 > cash Flow > depreciation

5379000

Annuals > 2 > cash Flow > change In Working Capital

-1007000

Annuals > 2 > cash Flow > cash From Operations

-63970000

Annuals > 2 > cash Flow > capital Expenditures

13861000

Annuals > 2 > cash Flow > cash From Investing

-16997000

Annuals > 2 > cash Flow > cash From Financing

174960000

Annuals > 2 > cash Flow > net Change In Cash

94292000

Annuals > 2 > cash Flow > currency_symbol

AUD

Annuals > 2 > ratios > PE

-0.33504268551782745

Annuals > 2 > ratios > PB

28.965018560875922

Annuals > 2 > ratios > ROE

-130.0873673553564

Annuals > 2 > ratios > ROA

-39.93959883495592

Annuals > 2 > ratios > FCF

-77831000

Annuals > 2 > ratios > Piotroski FScore

1

Annuals > 2 > ratios > fcf Percent

-0.48615205876474116

Annuals > 2 > health Score

13

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

7596000

Annuals > 3 > income Statement > cost Of Revenue

37361000

Annuals > 3 > income Statement > gross Profit

-29765000

Annuals > 3 > income Statement > operating Expenses

81121000

Annuals > 3 > income Statement > operating Income

-81247000

Annuals > 3 > income Statement > interest Expense

189000

Annuals > 3 > income Statement > pretax Income

-99039000

Annuals > 3 > income Statement > net Income

-80510000

Annuals > 3 > income Statement > eps

-0.28528805199039

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

282206000

Annuals > 3 > income Statement > income Tax Expense

-18529000

Annuals > 3 > income Statement > EBITDA

-70073000

Annuals > 3 > income Statement > operating Margin

-1069.6024223275408

Annuals > 3 > income Statement > total Other Income Expense Net

-17792000

Annuals > 3 > income Statement > currency_symbol

USD

Annuals > 3 > balance Sheet > cash

22037000

Annuals > 3 > balance Sheet > short Term Investments

-

Annuals > 3 > balance Sheet > receivables

20845000

Annuals > 3 > balance Sheet > inventories

3454000

Annuals > 3 > balance Sheet > total Current Assets

47543000

Annuals > 3 > balance Sheet > property Plant Equipment

6329000

Annuals > 3 > balance Sheet > total Assets

109813000

Annuals > 3 > balance Sheet > payables

11884000

Annuals > 3 > balance Sheet > short Term Debt

632000

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

106171000

Annuals > 3 > balance Sheet > equity

2158000

Annuals > 3 > balance Sheet > currency_symbol

AUD

Annuals > 3 > cash Flow > net Income

-80510000

Annuals > 3 > cash Flow > depreciation

5174000

Annuals > 3 > cash Flow > change In Working Capital

-2630000

Annuals > 3 > cash Flow > cash From Operations

-59328000

Annuals > 3 > cash Flow > capital Expenditures

1339000

Annuals > 3 > cash Flow > cash From Investing

-2726000

Annuals > 3 > cash Flow > cash From Financing

2846000

Annuals > 3 > cash Flow > net Change In Cash

-55908000

Annuals > 3 > cash Flow > currency_symbol

AUD

Annuals > 3 > ratios > PE

-0.28528805199039

Annuals > 3 > ratios > PB

975.559202965709

Annuals > 3 > ratios > ROE

-3730.7692307692305

Annuals > 3 > ratios > ROA

-73.31554551829018

Annuals > 3 > ratios > FCF

-60667000

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-7.986703528172723

Annuals > 3 > health Score

8

Valuation > metrics > PE

475.5

Valuation > metrics > PB

6.201563651221379

Valuation > final Score

1

Valuation > verdict

954.4% Overvalued

Profitability > metrics > ROE

-0.8253438276915492

Profitability > metrics > ROA

-0.8749623756007969

Profitability > metrics > Net Margin

-0.005871516926201244

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

1.8201857605684206

Risk > metrics > Interest Coverage

4.0271317829457365

Risk > final Score

46

Risk > verdict

High

Liquidity > metrics > Current Ratio

5.471044275522687

Liquidity > metrics > Quick Ratio

4.986776450535403

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

52.858190854485905

Prev Valuations > 1

40

Prev Valuations > 2

40

Prev Profitabilities > 0

36

Prev Profitabilities > 1

29

Prev Profitabilities > 2

63

Prev Risks > 0

47

Prev Risks > 1

59

Prev Risks > 2

70

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T22:42:10.624Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-02-18

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

BeforeMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-

Earnings History > 1 > period

2025-09-30

Earnings History > 1 > report Date

2025-10-14

Earnings History > 1 > date

2025-09-30

Earnings History > 1 > before After Market

-

Earnings History > 1 > currency

-

Earnings History > 1 > eps Actual

-0.09

Earnings History > 1 > eps Estimate

0

Earnings History > 1 > eps Difference

-0.09

Earnings History > 1 > surprise Percent

-

Earnings History > 2 > period

2025-06-30

Earnings History > 2 > report Date

2025-08-20

Earnings History > 2 > date

2025-06-30

Earnings History > 2 > before After Market

BeforeMarket

Earnings History > 2 > currency

-

Earnings History > 2 > eps Actual

0.01

Earnings History > 2 > eps Estimate

0.214

Earnings History > 2 > eps Difference

-0.204

Earnings History > 2 > surprise Percent

-95.3271

Earnings History > 3 > period

2025-03-31

Earnings History > 3 > report Date

2025-04-22

Earnings History > 3 > date

2025-03-31

Earnings History > 3 > before After Market

-

Earnings History > 3 > currency

-

Earnings History > 3 > eps Actual

0.0921

Earnings History > 3 > eps Estimate

0

Earnings History > 3 > eps Difference

0.0921

Earnings History > 3 > surprise Percent

-

Earnings History > 4 > period

2024-12-31

Earnings History > 4 > report Date

2025-02-20

Earnings History > 4 > date

2024-12-31

Earnings History > 4 > before After Market

-

Earnings History > 4 > currency

-

Earnings History > 4 > eps Actual

0.06

Earnings History > 4 > eps Estimate

0

Earnings History > 4 > eps Difference

0.06

Earnings History > 4 > surprise Percent

-

Earnings History > 5 > period

2024-09-30

Earnings History > 5 > report Date

2024-10-17

Earnings History > 5 > date

2024-09-30

Earnings History > 5 > before After Market

-

Earnings History > 5 > currency

-

Earnings History > 5 > eps Actual

0

Earnings History > 5 > eps Estimate

0

Earnings History > 5 > eps Difference

0

Earnings History > 5 > surprise Percent

-